For 2025, consolidated revenue was KRW 2,431.7bn, operating profit KRW 393.0bn and net profit attributable to owners KRW 329.9bn, for a 16.2% operating margin.
The margin path runs from 1.7% in 2022 (revenue KRW 3,719.3bn, operating profit KRW 64.9bn) to 2.7% in 2023 (KRW 3,436.7bn, KRW 94.4bn) and 9.7% in 2024 (KRW 2,272.8bn, KRW 221.1bn), so profitability improved for four straight years even as reported revenue shrank.
Because a holding company's consolidated revenue depends heavily on which subsidiaries are consolidated and on business transfers, the absolute revenue line is a poor gauge of group scale.
Net profit attributable to owners was only KRW 0.07bn in 2023 before turning to KRW 453.2bn in 2024 and KRW 329.9bn in 2025, and in 2024 net profit far exceeded operating profit, showing the weight of non-operating items such as equity-method gains.
Quarterly, revenue and operating profit moved from KRW 601.9bn and KRW 99.1bn in 2Q25 to KRW 612.2bn and KRW 121.9bn in 3Q25, KRW 663.7bn and KRW 90.2bn in 4Q25, KRW 530.2bn and KRW 94.6bn in 1Q26, and KRW 733.6bn and KRW 231.6bn in 2Q26.
First-quarter 2026 revenue fell 4.3% year on year while operating profit rose 15.6%, according to the company's disclosure. The second-quarter 2026 operating margin exceeded 30%, the highest quarterly level in the reported window, and net profit attributable to owners widened to KRW 195.3bn.
Simultaneous improvement at affiliates is cited as the driver: equity-method income of KRW 147.0bn in 2Q26 was up 169% year on year and 214% quarter on quarter, with Hyosung TNC contributing most and other core affiliates including Hyosung Chemical also improving (BNK Investment & Securities, August 2026).
Operating cash flow, however, was KRW 421.1bn in 2025 versus KRW 464.8bn in 2024, while total liabilities rose from KRW 1,836.4bn to KRW 2,529.9bn and the debt-to-equity ratio climbed from 73.3% to 88.5%.